Comparative efficacy on steroid-free remission of pharmacological therapies for moderate-to-severe ulcerative colitis: A systematic review and network meta-analysis

被引：0
|
作者：
Paschos, P. [1 ,2 ]
Katsoula, A. [3 ]
Giouleme, O. [3 ]
Tsapas, A. [1 ,4 ]
机构：
[1] Aristotle Univ Thessaloniki, Med Dept 2, Clin Res & Evidence Based Med Unit, Thessaloniki, Greece
[2] Papageorgiou Hosp, Dept Internal Med 1, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Propedeut Med Dept 2, Thessaloniki, Greece
[4] Univ Oxford, Harris Manchester Coll, Oxford, England
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P670
引用
收藏
页码：S449 / S450
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of vedolizumab in the treatment of patients with moderate to severe Ulcerative Colitis: a systematic review and meta-analysis
    Khorshid, M.
    Alboraie, M.
    Abbas, W.
    Sayed, Z. E.
    El-Nady, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S516 - S517
  • [32] THE PROGNOSTIC VALUE OF ENDOSCOPIC MAYO SCORE 0 VERSUS 1 IN PATIENTS WITH ULCERATIVE COLITIS IN STEROID-FREE CLINICAL REMISSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Valvano, M.
    Stefanelli, G.
    Vernia, F.
    Longo, S.
    Castellini, C.
    Frieri, G.
    Latella, G.
    Viscido, A.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S155 - S156
  • [33] Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis
    Shehab, Mohammad
    Alrashed, Fatema
    Alsayegh, Abdulwahab
    Aldallal, Usama
    Ma, Christopher
    Narula, Neeraj
    Jairath, Vipul
    Singh, Siddharth
    Bessissow, Talat
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (02) : 250 - 262
  • [34] Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
    Yan, Ting
    Wang, Ting
    Tang, Mei
    Liu, Nan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life
    Paschos, Paschalis
    Katsoula, Anastasia
    Salanti, Georgia
    Giouleme, Olga
    Athanasiadou, Eleni
    Tsapas, Apostolos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1174 - 1185
  • [36] Induction of response and remission: a network meta-analysis of induction studies comparing ontamalimab with other treatments for moderate-to-severe ulcerative colitis
    Vickers, A.
    Nag, A.
    Devine, B.
    Sands, B. E.
    Panaccione, R.
    Peyrin-Biroulet, L.
    Danese, S.
    Vermeire, S.
    Gorelick, K. J.
    Goetsch, M.
    Hartley, L.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S327 - S328
  • [37] Comparison of efficacy of targeted therapies without topical corticosteroids for moderate-to-severe atopic dermatitis: systematic review and network meta-analysis
    Silverberg, J. I.
    Hong, H. C.
    Thyssen, J. P.
    Calimlim, B. M.
    Joshi, A. D.
    Teixeira, H. D.
    Collins, E. B.
    Crowell, M. M.
    Johnson, S. J.
    Armstrong, A. W.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E130 - E131
  • [38] Network meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis
    Zhang, Wenkai
    Zhao, Songbo
    Li, Jipin
    Sun, Yihua
    Wang, Xiang
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [39] Systematic review and bayesian network meta-analysis: comparative efficacy and safety of six commonly used biologic therapies for moderate-to-severe Crohn's disease
    Su, Haohang
    Xiao, Shengwei
    Liang, Zhiqing
    Xun, Tianrong
    Zhang, Jinfang
    Yang, Xixiao
    FRONTIERS IN PHARMACOLOGY, 2025, 15
  • [40] Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
    April W. Armstrong
    Ahmed M. Soliman
    Keith A. Betts
    Yan Wang
    Yawen Gao
    Luis Puig
    Matthias Augustin
    Dermatology and Therapy, 2021, 11 : 885 - 905
12345